Molecular mechanism and regulatory function of protein coding gene transcriptional termination in mammalian genomes.
In plain English
AI plain-English summaryEvery time a human cell reads a gene to make a protein, it must also know exactly where to stop reading—and that stop signal is frequently ignored or misread in cancer cells. This research tackles a fundamental gap in genomics: we can sequence entire human genomes, but we still do not understand how cells define where one gene ends and the next begins. The project will map, for the first time, which of the thousands of protein-coding genes use which molecular mechanism to terminate transcription. It will also explain why certain proteins thought to be universal terminators actually only work on a subset of genes, and how termination failures—common in cancer—produce fused, abnormal transcripts. This is fundamental science. It does not promise a new drug or diagnostic tomorrow. But understanding how transcription units are defined is a prerequisite for interpreting the thousands of cancer genomes now being sequenced. Without knowing where a gene normally stops, you cannot tell whether a fused transcript is a driver of disease or a harmless artifact. Past work on transcription termination has already revealed mechanisms that underpin RNA-based therapies; this project could provide the genomic context needed to make sense of the next wave of cancer genomics data.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know